Search results
Ligand Pharmaceuticals exec sells over $1.4m in stock By Investing.com
Investing.com· 10 hours agoIn a recent move, Matthew E. Korenberg, the President and Chief Operating Officer of Ligand ...
Takeda’s dengue vaccine obtains WHO prequalification
Pharmaceutical Technology via Yahoo Finance· 1 hour agoDengue, a mosquito-borne disease, poses a significant health threat with an estimated 100 to 400 million cases annually. The disease is prevalent in...
Q1 2024 Acurx Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 7 hours agoAdditional data from the Phase IIb clinical trial showed ibezapolstat, but not vancomycin, consistently preserved and allowed regrowth of key gut bacteria species believed to confer
Tracking the opioid lawsuit settlements amidst calls for oversight
Pharmaceutical Technology via Yahoo Finance· 3 hours agoIn 2021, nationwide settlements were agreed upon in response to legal action brought by states and...
PMV Pharmaceuticals, Inc. to Post FY2025 Earnings of ($1.47) Per Share, HC Wainwright Forecasts...
ETF DAILY NEWS· 6 hours agoPMV Pharmaceuticals, Inc. (NASDAQ:PMVP – Free Report) – Research analysts at HC Wainwright issued their FY2025 earnings per share estimates for shares of PMV Pharmaceuticals ...
UN agency authorizes second vaccine against dengue amid outbreaks in the Americas - The Morning Sun
The Morning Sun· 1 day agoIn a statement on Wednesday, the U.N. health agency said it approved the dengue vaccine made by the...
Earnings call: Acurx Pharmaceuticals outlines ibezapolstat progress By Investing.com
Investing.com· 12 hours agoAcurx Pharmaceuticals, Inc. (ticker ACXP) provided a comprehensive update on their progress with...
Earnings call: Atea Pharmaceuticals reports progress in COVID-19 trial
Investing.com· 1 day agoAtea Pharmaceuticals, a biopharmaceutical company focused on developing therapeutics for viral...
Cardinal Health shares target cut by Argus amid contract pressures By Investing.com
Investing.com· 22 hours agoCardinal Health, recognized as one of the leading distributors of pharmaceuticals in the United...
Bausch Health to defend patents against Norwich By Investing.com
Investing.com· 2 days agoBausch Health (TSX:BHC) Companies Inc. (NYSE:BHC)(TSX:BHC) and Salix Pharmaceuticals, its...